chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Son/caregiver called to report patient was experiencing a decreased mental acuity accompanied with fatigue and loss of appetite after receiving her 2nd dose of Moderna Covid 19 vaccine since Febuary 27th, 2021. Son describer the symptoms as progressive starting after receiving the vaccine.  It was recommend the patient's primary care provider be contacted to receive further advice.
First dose administered to a 17 yr old Pediatric patient; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose administered to a 17 yr old Pediatric patient) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose administered to a 17 yr old Pediatric patient). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose administered to a 17 yr old Pediatric patient) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
patient older than 13 years of age was administered PROQUAD instead of MMR II and VARIVAX; patient older than 13 years of age was administered PROQUAD instead of MMR II and VARIVAX; This spontaneous report was received from the nurse and refers to a patient of an unknown gender and exact age (reported as older than 13 years of age). The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 24-JUN-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, for prophylaxis (dose, strength, lot #, expiry date, and route of administration were not provided) instead of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and varicella virus vaccine live (oka/merck) (VARIVAX) (product administered to patient of inappropriate age) (wrong product administered).; Sender's Comments:  US-009507513-2207USA000734: US-009507513-2207USA000538: US-009507513-2207USA000766:
After the first dose (9/22/21), I had a two week menstrual cycle, a week and half without bleeding, then had another menstrual cycle (or just uterine bleeding) for 5 days.  After the second dose (10/24/21), I started either another menstrual cycle or uterine bleeding less than 6 hrs after the vaccine was administered
At one am the night following receiving the injection I woke up with severe pain in my left arm where I received the injection. The pin radiated from elbow to shoulder. I had severe chills, vomiting, and uncontrollable shaking. I had body aches, headaches, and fatigue for the following two days from onset of symptoms. I had a confirmed case of Covid-19 on 9/8/2020 and my symptoms from the injection were at points more server than my symptoms from Covid.
Heavy Vaginal Bleeding; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL HAEMORRHAGE (Heavy Vaginal Bleeding) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B21A and 002C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-May-2021, the patient experienced VAGINAL HAEMORRHAGE (Heavy Vaginal Bleeding). On 17-May-2021, VAGINAL HAEMORRHAGE (Heavy Vaginal Bleeding) had resolved.            Concomitant medications were not provided Treatment information was not provided.
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. Medical history was not reported. The nurse informed that on 22-JUL-2014 the patient was vaccinated with M-M-R II (strength, dosage and route were not reported) lot number: J008728, expiration date: 26-JUL-2015. That may had been improperly stored since February 2014. The thermometer battery ran out in February 2014, so the refrigerator temperature was not able to be confirmed to be within recommended storage temperature since then. The highest temperature the M-M-R II could had been exposed was 70F. Also stated that was no way to determine what the exact temperature was at any given time after 01-FEB-2014 since the battery in the thermometer stopped working. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
4:30- chills, headache 5:00- chills worsened, headache, pressure in my head when I moved  6:00- hurt to breath when laying down 6:30- 101 degree fever  7:30- pain in my head worsened when I moved  8:00- bed  *woke up every 10 min* *next day* 6:00- 100 degree fever, still hurt to stand, nauseous, really really weak, chills 7:00- chills and hot flashes (with same symptoms as before) 12:00- started to feel a little better- still cold and headache  8pm- feeling okay *next day* Clammy but good
Patient received vaccine and was in the monitoring center when she made staff aware of tingle in lips. Patient vitals were taken and stable with elevated blood pressure due to not taking morning medication. While documenting and staying with the patient stated that the tingle was moving into cheeks and throat. Per 25mg IM once given. Patient symptoms resolved within 15 mins. Vitals stables and discharged home.
I WAS PREGNANT AT THE TIME. BABY WAS BORN 4/28/22. I DEVELOPED A TEMPORARY HYPERTHYROIDISM WHICH HAS NOW RESOLVED, ABOUT 6 WEEKS AFTER HIS BIRTH. DX POSTPARTUM THYROIDITIS. I DO NOT SUSPECT THAT THIS WAS DUE TO THE VACCINE BUT RATHER DUE TO THE PREGNANCY.
Patient reported feeling weakness and heaviness in legs, became dizzy and passed out. Husband called 911 and patient was transported to the hospital.
She has developed shortness of breath, which was new and more worse then her usal sthma symtoms. She went to urgent care center, she has D dimer of 7000, She has CT scan doen for pulmonary embolism on 4/6/2021, She right side pulmonary embolism diagnosis as per CT chest.
Mild discomfort at injection site on day of vaccine. Next morning every muscle, joint, bone and hair hurt. Extreme fatigue. Didn't want to keep eyes open. Proceeded to carry on with daily activities, but after 2.5 hours was so fatigued had to be taken home. Took Tylenol 1000 mg for pain relief. Woke up from sleep in about 2 hours because both thumbs and index fingers were in spasm/cramp like a fist and tingling started in right ring, middle and index fingers and left ring finger only. No loss of sensation or capillary refill. Placed wrist braces (for carpal tunnel) to hold fingers in correct position. No real relief, When removed, symptoms were worse. Tingling eventually spread to whole fingers and thumb pad area. Soaked in warm/hot bath for 20-30 min. Slowly noticed relief of tingling. After bath, went back to bed with hands propped on pillows. Slowly over the next hour the spasm/cramps resolved and as well as all tingling. Note: at no time was the ability to move or control all fingers and hands lost. After eating about 1 cup of food, was  fatigued and went to sleep. The next morning fatigue remained, but not as bad. Ate 1/2 of a breakfast at 1030. Went immediately back to bed. Upon waking at 1400 it was noted that I must have sweated, but was never aware that there was a fever. at this time all symptoms were resolved. None have followed.
Became out of breath; Speech was impaired due to numbness on Sunday; Intensification of numbness on left side of face; New numbness right side of face including drooping right eye lid.; Pain shot to my left foot; Sore throat feeling like had a virus; Cough; Fever went to 101.2; Pain at shot area; Excrutiating headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain shot to my left foot), OROPHARYNGEAL PAIN (Sore throat feeling like had a virus), HYPOAESTHESIA (Intensification of numbness on left side of face), EYELID PTOSIS (New numbness right side of face including drooping right eye lid.) and DYSPNOEA (Became out of breath) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (covid survivor and was long haul before these vaccines.). Concurrent medical conditions included Asthma (severe asthmatic.). Concomitant products included IBUPROFEN for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced PAIN IN EXTREMITY (Pain shot to my left foot), OROPHARYNGEAL PAIN (Sore throat feeling like had a virus), EYELID PTOSIS (New numbness right side of face including drooping right eye lid.), COUGH (Cough), PYREXIA (Fever went to 101.2), VACCINATION SITE PAIN (Pain at shot area) and HEADACHE (Excrutiating headache). On 06-Oct-2021, the patient experienced HYPOAESTHESIA (Intensification of numbness on left side of face). On 10-Oct-2021, the patient experienced SPEECH DISORDER (Speech was impaired due to numbness on Sunday). On 11-Oct-2021, the patient experienced DYSPNOEA (Became out of breath). At the time of the report, PAIN IN EXTREMITY (Pain shot to my left foot), OROPHARYNGEAL PAIN (Sore throat feeling like had a virus), HYPOAESTHESIA (Intensification of numbness on left side of face), EYELID PTOSIS (New numbness right side of face including drooping right eye lid.), DYSPNOEA (Became out of breath), SPEECH DISORDER (Speech was impaired due to numbness on Sunday), COUGH (Cough), PYREXIA (Fever went to 101.2), VACCINATION SITE PAIN (Pain at shot area) and HEADACHE (Excrutiating headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.2 (High) fever went to 101.2.         Patient took 2 ibuprofen over 9 hours prior to the 2nd shot and taken no otcs including ibuprofen or vitamins after.  No treatment information was provided.   This case was linked to MOD-2021-323555 (Patient Link).
Site: Bruising at Injection Site-Medium, Additional Details: pt  had pain in left shoulder beginning the day of the injection. she went ot the general practicitoner after 30 days. she got a rx for predisone & pain pill. on 1/12/23  went to ortho. xrays & tests showed the injection went through the deltoid muscle into the bursa. she is now on panin meds & got a cortisone injection
This case was reported by a other health professional via call center representative and described the occurrence of delayed type hypersensitivity in a 47-year-old female patient who received FLUARIX QUADRIVALENT (batch number C242G, expiry date 30th June 2016). Previously administered products included Flu vaccine (no problems with previous flu vaccinations). On 25th September 2015, the patient received FLUARIX QUADRIVALENT (subcutaneous) .5 ml. On 25th September 2015, 2 hrs after receiving FLUARIX QUADRIVALENT, the patient experienced delayed type hypersensitivity (serious criteria other: serious as per reporter), rash (serious criteria other: serious as per reporter), tingling mouth (serious criteria other: serious as per reporter), extensive swelling of vaccinated limb (serious criteria other: serious as per reporter) and intramuscular formulation administered by other route. The patient was treated with BENADRYL (nos). On an unknown date, the outcome of the delayed type hypersensitivity, rash, tingling mouth, extensive swelling of vaccinated limb and intramuscular formulation administered by other route were unknown. The reporter considered the delayed type hypersensitivity, rash, tingling mouth and extensive swelling of vaccinated limb to be almost certainly related to FLUARIX QUADRIVALENT. It was unknown if the reporter considered the intramuscular formulation administered by other route to be related to FLUARIX QUADRIVALENT. Additional details were provided as follows: The patient received FLUARIX QUADRIVALENT, subcutaneously which led to inappropriate route of vaccine administration. This patient received the vaccination in her right deltoid and experienced a delayed hypersensitivity reaction approximately two hours after the vaccination. She had swelling in her right hand to the point that she could not make a fist. She also developed a fine pinpoint rash extending up her arms and tingling around mouth. Her vitals were accessed and she was not experiencing any difficulty breathing, her blood sugar was normal and lungs clear. She was advised to take BENADRYL and seek medical attention if any symptoms worsened.
Patient was given 2nd Hepatitis A vaccine 2 months after first dose normal interval 6 months.
Patient received vaccine intended for use in 18 y/o and older, she was only 16 yrs 11 mths at the time of vaccination.  Patient has had no adverse events related to administration
Patient called complaining of localized swelling the size of a silver dollar and pain around injection site. Recommended anti-inflammatory and BENADRYL. Patient does not want to take any medications due to ongoing Heart Disease and Diabetes. Patient is icing arm and calling MD.
pt recv vax & w/in 24hr post vax pt exp enlarged liver (by physical exam), fatigue, facial flushing, nausea, joint aches, fever & an itchy rash;ER or MD visit was required;sonography subsequently showed a nl-sized liver;tx rest;sx res
The vaccine gave me the typical reactions such as fever, chills, tiredness, and a headache. Although, the pain spread from my arm to my legs. I started to feel weak as time went by and eventually by 10:00pm it became severe. I had developed a lump on shoulder and a rash formed. My left side of my body was numb and on Sunday March 14, 2021 I was dizzy and could barely move. It is not Monday March 15, 2021 and the lump grew larger and is now on my neck. My left arm hurts but some of my strength returned.
Patient came back into pharmacy 2 days after injection with a large (maybe 4 to 5 inch diameter) red spot around the site of injection. She stated it was painful and was slightly warm to the touch. Patient was instructed to take BENADRYL and to go to doctor/ER is symptoms worsened or signs and symptoms of anaphylactic reaction.
11 year old female had syncopal episode after 1st dose of GARDASIL 9 received in conjunction TDAP and Menactra.; This spontaneous report was received from an office manager via company representative referring to a 11-year-old female patient. Information about patient's pertinent concurrent conditions, medical history, concomitant medications and previous drug reactions or allergies was unknown by the reporter.     On 27-AUG-2020, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) as routine immunization (prophylaxis) (concentration route and anatomical location of administration, dose, vaccination scheme frequency, lot number and expiration date were unknown by the reporter). Also, on the same day, the patient was vaccinated with diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid (reported as TDAP) and meningococcal acyw conj vaccine (dip toxoid)(MENACTRA) (concentration, indication, number of administered dose, route and anatomical location of administration, lot number and expiration date were not reported).    On 27-AUG-2020, the patient experienced syncope episode. The outcome of syncope was not reported. It was unknown by the reporter if the patient sought medical attention, if any laboratory diagnostic or if any treatment was given to the patient.  The causality assessment between all the suspect vaccines and the aforementioned event was not reported.  Upon internal review, syncope was determined to be medically significant event.
On Dec 25 developed fever, chills, headache and general fatigue with no desire to engage in normal family activities. Dec 26,27,28 were spent in bed with a low energy level and headache mimicking severe sinus pain. No fever after Dec 26. Headache and general fatigue lessened gradually after Dec 28.  I would not have been able to perform my normal occupation the week of Dec 27 to Jan 2. Full recovery the week of Jan 3.
3 hours post vax, the pt experienced a fever of 104.7, then she vomited and was taken to the ER and treated with IV fluids and IV Rocephin. No rash was noted.
SUSPECTED CLINICAL VACCINE FAILURE; LOSS OF HEARING; SWOLLEN TONSILS; LOSS OF APPETITE; TIREDNESS; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a parent concerned a 25 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was not pregnant at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Reporter unaware about the exact date on which the patient got the COVID-19 vaccine. No concomitant medications were reported.  On unspecified date patient experienced tiredness. On 22-JUL-2021, the patient experienced suspected covid-19 infection. According to reporter patient got COVID because patient was exposed to it. The patient did not take any medications for the tiredness nor report it to Health care professional (HCP). In regards to testing positive for COVID-19, HCP was aware of this but had not been given any treatments for COVID-19 symptoms. Laboratory data included: COVID-19 virus test (NR: not provided) Positive.  On an unspecified date, the patient experienced suspected clinical vaccine failure, loss of hearing, swollen tonsils, and loss of appetite. Patient was at home isolating without medical treatment. Reporter did not have lot information but will have daughter call to provide further information on this report. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from loss of hearing, and tiredness, had not recovered from suspected covid-19 infection, swollen tonsils, and loss of appetite, and the outcome of suspected clinical vaccine failure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20210758347-covid-19 vaccine ad26.cov2.s -'Suspected  clinical vaccination failure'. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS 20210758347-covid-19 vaccine ad26.cov2.s- suspected covid-19 infection, loss of hearing. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Pt recv vax on 2/2/99; on same day pt exp sinus pressure, tiredness
The vaccine was administered in my upper left arm. The pharmacist did not tell me I had to wait 15 minutes after receiving my first dose. About an hour or so later, my fingers on my left hand started to swell up. I had pins & needles in my hand when I woke up  the next morning. The effects have gone away and the swelling has gone down.
irst dose of Moderna Covid-19 was on 12-28-20 and second dose of vaccine was on 1-29-21. 2-3 months after receiving both doses of the Covid-19 Moderna vaccine, patient started experiencing extreme amounts of pelvic pain, pressure, cramping, lower back pain, nausea, weight gain, headaches and amenorrhea. Patient was seen at medical facility on 5/7/21 and was advised to have a pelvic with transvaginal ultrasound done. Patient had US done on May 13, 2021 and was then referred to second medical facility for further evaluation. After second Pelvic US on 5/25/21  through second medical facility patient was informed at this visit that she had cysts on her ovaries and that she should follow up as needed. Patient had been seeing  Dr. at chiropractic facility for chiropractic care and  after 3 months of no relief from symptoms patient decided to seek help through this provider. After evaluation from Dr., provider suggested patient have further lab work done to get her hormones checks along with multiple other labs.  Date of labs  through Dr. were 8/5/21.  Once lab results came back on 8/16/21, patient was diagnosed with PCOS, hyperthyroid, Vitamin D Deficiency and Adrenal Exhaustion.
Pfizer COVID-19 vaccine was given 24 hours after draw time. Called manufacture and CDC  and was determined re- dose was not necessary.
14Mar96 pt recv 1 dose vax. 02Mar98 pt devel 9 vesicles, "watery blisters". Vesicles located on back,diaper area,chest & neck. Pt was afebrile. Not seen by MD. "Rash started as red & pimply".
This case was reported by a other health professional via call center representative and described the occurrence of shingles in a 74-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included shingles (experienced 4 times previously). Previously administered products included Valtrex and Acyclovir. Concurrent medical conditions included antiviral treatment. In May 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced shingles, pruritus, gastrointestinal disorder, inflammation, pain in hand and hives. The patient was treated with benadryl (nos) (Benadryl). On an unknown date, the outcome of the shingles, pruritus, inflammation, pain in hand and hives were not recovered/not resolved and the outcome of the gastrointestinal disorder was recovered/resolved.  It was unknown if the reporter considered the shingles, pruritus, gastrointestinal disorder, inflammation, pain in hand and hives to be related to SHINGRIX. Additional information was reported as follows: The reporter was the patient. The patient was vaccinated with SHINGRIX and soon after vaccination the patient experienced itching and hives that the patient stated would not go away.  The area was also inflamed. The patient's nurse diagnosed her with shingles. The patient had gastro-intestinal problems for a few weeks, but they had resolved. The pain and itching had radiated from her arm to her hand. She took Benadryl but it had no effect on her condition. The patient's previous bouts with shingles were not on the same location as experienced this time.
I started noticing chicken pox-like bumps on my back, shoulders, elbows, ear, and nose by Friday night/Saturday morning.  They continued to spread and I began to feel flu-like symptoms on Monday the 5th (5 days after the injection) I saw a doctor virtually and sent her pictures and she believes I have contracted chicken pox from the vaccine as I have not been in contact with anyone that has had chicken pox